← Eichor
Study identifier: NCT03423758 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma

Condition: Glaucoma  ·  Sponsor: Medical University of Vienna

PhaseN/A
Planned participants300
Who can joinAll sexes, 21 Years to 105 Years
Healthy volunteersYes

About this study

There is increasing evidence that there are genetic risk factors for several forms of glaucoma, such as glaucoma caused by pseudoexfoliation syndrome (PXF) ,primary angle closure glaucoma (PACG) and primary open-angle glaucoma (POAG). The aim of the present prospective, multi-center, case-control study is to identify susceptibility genes/loci for PXF, PACG and POAG using a whole genome association (WGA) approach.

This description comes directly from the study's public registry record.

Talk to the study team

Gerhard Garhöfer  ·  0140 400 29880  ·  gerhard.garhoefer@meduniwien.ac.at

Doreen Schmidl  ·  0140 400 29880  ·  doreen.schmidl@meduniwien.ac.at

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Clinical Pharmacology, Medical University of ViennaVienna, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03423758